Liver diseases are hepatic pathological changes caused by numerous endogenous and exogenous pathogenic factors such as drugs, chemical agents, viral infection, chronic alcohol consumption and malnutrition
Because GLP-1 medications already influence digestion and appetite regulation, poor sleep can amplify the way side effects are perceived
Because they're patented properties, it's unclear how these branded forms can withstand the digestive environment, but both have demonstrated their potential to do so in clinical studies
By Vivian Ewing The F.D.A
Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.